Contrasting Nutra Pharma (NPHC) and Entia Biosciences (ERGO)

Nutra Pharma (OTCMKTS:NPHC) and Entia Biosciences (OTCMKTS:ERGO) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations and dividends.

Valuation & Earnings

This table compares Nutra Pharma and Entia Biosciences’ revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Nutra Pharma $120,000.00 8.33 -$4.02 million N/A N/A
Entia Biosciences $260,000.00 1.31 -$1.39 million N/A N/A

Entia Biosciences has higher revenue and earnings than Nutra Pharma.

Profitability

This table compares Nutra Pharma and Entia Biosciences’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Nutra Pharma -4,940.00% N/A -1,875.70%
Entia Biosciences N/A N/A N/A

Analyst Ratings

This is a breakdown of recent recommendations for Nutra Pharma and Entia Biosciences, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nutra Pharma 0 0 0 0 N/A
Entia Biosciences 0 0 0 0 N/A

Risk & Volatility

Nutra Pharma has a beta of 7.34, meaning that its share price is 634% more volatile than the S&P 500. Comparatively, Entia Biosciences has a beta of 6.44, meaning that its share price is 544% more volatile than the S&P 500.

Insider & Institutional Ownership

0.0% of Nutra Pharma shares are held by institutional investors. 20.9% of Nutra Pharma shares are held by company insiders. Comparatively, 28.3% of Entia Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Entia Biosciences beats Nutra Pharma on 5 of the 8 factors compared between the two stocks.

Nutra Pharma Company Profile

Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating back pain, neck pain, headaches, joint pain, migraines, and neuralgia, as well as a topical gel for treating joint pain, neck pain, arthritis pain, and pain associated with repetitive stress; Pet Pain-Away, an over-the-counter pain reliever to treat pain in cats and dogs; Luxury Feet, an over-the-counter pain reliever to treat foot pain from high heels and stilettos; Nyloxin Military Strength for treating pain to the United States Military and Veteran's Administration; and Equine Nyloxin, a topical therapy for chronic pain in horses. It is also developing RPI-78M to treat neurological diseases and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases, including human immunodeficiency virus/AIDS and herpes; RPI-78 for pain and arthritis; and RPI-70 for pain. The company has a collaboration agreement with the International Security Group to develop nerve agent counter measures. Nutra Pharma Corp. was founded in 2000 and is based in Coral Springs, Florida.

Entia Biosciences Company Profile

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.

Receive News & Ratings for Nutra Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutra Pharma and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply